-
Je něco špatně v tomto záznamu ?
High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2
Seeman P, Sakmaryová I.
Jazyk angličtina Země Dánsko
Grantová podpora
NM7417
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Wiley Online Library (archiv)
od 1997-01-01 do 2012-12-31
- MeSH
- alely MeSH
- financování organizované MeSH
- genetické testování MeSH
- kohortové studie MeSH
- konexiny genetika MeSH
- lidé MeSH
- místa sestřihu RNA genetika MeSH
- mutace MeSH
- mutační analýza DNA MeSH
- oboustranná nedoslýchavost diagnóza epidemiologie genetika MeSH
- restrikční mapování MeSH
- Check Tag
- lidé MeSH
- Geografické názvy
- Česká republika MeSH
Biallelic pathogenic GJB2 gene mutations cause pre-lingual genetic hearing loss in up to 50% of individuals with bilateral sensorineural hearing loss worldwide. Sequencing of the entire GJB2 gene-coding region in Czech patients with pre-lingual bilateral hearing loss revealed that 10.3% of Czech patients carry only one monoallelic pathogenic mutation in the coding region of the GJB2 gene, which is significantly more than the population frequency of 3.4%. The 309-kb GJB6 deletion, frequent in Spain and France, is very rare in the Czech population. In order to evaluate the impact of the IVS1 + 1 G to A splice site mutation in the non-coding part of the GJB2 gene among Czech patients, we tested all available patients with pre-lingual hearing loss with only one monoallelic mutation in the coding part of GJB2. By sequencing of the exon 1 region of the GJB2 gene and HphI restriction analysis in 20 Czech patients we identified nine patients carrying IVS1 + 1 G to A. Testing for this mutation explained deafness in 45% of Czech GJB2 monoallelic patients. This mutation represents now 4% of GJB2 pathogenic mutations in Czech patients and is the third most common GJB2 mutation found in our cohort of 242 unrelated Czech patients with prelingual hearing loss. A similar frequency may also be expected in other Central European or Slavic populations.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522073
- 003
- CZ-PrNML
- 005
- 20130514143252.0
- 008
- 090426s2006 dk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Seeman, Pavel, $d 1966- $7 xx0037870
- 245 10
- $a High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2 / $c Seeman P, Sakmaryová I.
- 314 __
- $a Department of Child Neurology, DNA Laboratory, Charles University Prague, 2nd School of Medicine, Prague, Czech Republic. pseeman@yahoo.com
- 520 9_
- $a Biallelic pathogenic GJB2 gene mutations cause pre-lingual genetic hearing loss in up to 50% of individuals with bilateral sensorineural hearing loss worldwide. Sequencing of the entire GJB2 gene-coding region in Czech patients with pre-lingual bilateral hearing loss revealed that 10.3% of Czech patients carry only one monoallelic pathogenic mutation in the coding region of the GJB2 gene, which is significantly more than the population frequency of 3.4%. The 309-kb GJB6 deletion, frequent in Spain and France, is very rare in the Czech population. In order to evaluate the impact of the IVS1 + 1 G to A splice site mutation in the non-coding part of the GJB2 gene among Czech patients, we tested all available patients with pre-lingual hearing loss with only one monoallelic mutation in the coding part of GJB2. By sequencing of the exon 1 region of the GJB2 gene and HphI restriction analysis in 20 Czech patients we identified nine patients carrying IVS1 + 1 G to A. Testing for this mutation explained deafness in 45% of Czech GJB2 monoallelic patients. This mutation represents now 4% of GJB2 pathogenic mutations in Czech patients and is the third most common GJB2 mutation found in our cohort of 242 unrelated Czech patients with prelingual hearing loss. A similar frequency may also be expected in other Central European or Slavic populations.
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a konexiny $x genetika $7 D017630
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a genetické testování $7 D005820
- 650 _2
- $a oboustranná nedoslýchavost $x diagnóza $x epidemiologie $x genetika $7 D006312
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a místa sestřihu RNA $x genetika $7 D022821
- 650 _2
- $a restrikční mapování $7 D015183
- 650 _2
- $a financování organizované $7 D005381
- 651 _2
- $a Česká republika $7 D018153
- 700 1_
- $a Dolinová, Iva $7 xx0070781
- 773 0_
- $w MED00001127 $t Clinical genetics $g Roč. 69, č. 5 (2006), s. 410-413 $x 0009-9163
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090312170439 $b ABA008
- 991 __
- $a 20130514143604 $b ABA008
- 999 __
- $a ok $b bmc $g 645162 $s 498078
- BAS __
- $a 3
- BMC __
- $a 2006 $b 69 $c 5 $d 410-413 $i 0009-9163 $m Clinical genetics $x MED00001127
- GRA __
- $a NM7417 $p MZ0
- LZP __
- $a 2009-B1/vtme